Manufacturers wanting to apply these strategies have to present sturdy validation data to show their equivalence to pharmacopoeial techniques. As these new systems arise, the WHO emphasizes the necessity of a thorough hazard assessment and validation approach. To validate decontamination cycles, many biological indicators commonly inocula